This study demonstrates the engineering of biologically active heart valve leaflets using prenatally available human umbilical cord-derived progenitor cells as the only cell source. Wharton's Jelly-derived cells and umbilical cord blood-derived endothelial progenitor cells were subsequently seeded on biodegradable scaffolds and cultured in a biomimetic system under biochemical or mechanical stimulation or both. Depending on the stimulation, leaflets showed mature layered tissue formation with functional endothelia and extracellular matrix production comparable with that of native tissues. This demonstrates the feasibility of heart valve leaflet fabrication from prenatal umbilical cord-derived progenitor cells as a further step in overcoming the lack of living autologous replacements with growth and regeneration potential for the repair of congenital malformation.
INTRODUCTION
A PPROXIMATELY 275,000 PATIENTS undergo heart valve replacement each year 1 and have to deal with severe side effects, such as life-long anticoagulation therapy, increased risks for infections, and thromboembolism, as the currently used replacement materials are synthetic or bioprostethic. 2, 3 Glutaraldehyde-fixed or cryopreserved biological valves do not require an anticoagulation therapy but represent nonviable prostheses suffering from structural dysfunction due to progressive tissue deterioration. 4, 5 Thus, they necessitate re-replacement within 10 to 15 years. Because of higher immunological competence, their durability is even less in younger individuals. In addition, their availability is limited. Being non-viable structures, all clinically available valve prostheses, except the pulmonary autograft, lack the ability to grow, repair, or remodel.
These disadvantages could be avoided by valve replacements that closely mimic their native counterparts and comprise adequate mechanical function, durability, good hemodynamic performance, and the absence of immunogenic, thrombogenic, and inflammatory reactions. 6 In particular, pediatric patients would benefit from living replacement materials with growth and regeneration potential, because the currently used non-living prostheses necessitate re-operations because of their lack of growth. 2 Tissue engineering aims to overcome the limitations of currently used prostheses by using the in vitro fabrication of living autologous tissue replacements with the capacity for growth, remodeling, and regeneration. In previous studies, the concept of engineering living, functional heart valves from ovine vascular-derived cells has been demonstrated in animal models. 7 Furthermore, the in vitro methodology has been transferred successfully from animal to human by using human cell sources including bone marrow-derived mesenchymal cells. 8 However, the ideal cell source for the in vitro fabrication of living autologous biologically active heart valve replacements for the repair of congenital malformation in newborns has not been identified. In addition to easy access, the ideal cell source must allow prenatal cell harvesting as soon as the cardiovascular defect is detected, in order to have the autologous, tissue-engineered replacement ready to use at or shortly after birth and to prevent secondary damage to the newborn's immature heart. In addition, an ideal cell source should provide all types of cells required for the tissue-engineering process. The obtained cells should have a high potential for growth and characteristics similar to those of their native counterpart.
A promising cell source is the umbilical cord, because it provides a variety of cell types, including progenitor cells, 9, 10 and allows easy sampling of tissue and blood-derived progenitor cells (e.g., by cordocentesis and biopsy using today's advanced operative fetoscopic technology). [11] [12] [13] [14] In particular, endothelial progenitor cells (EPCs), which are obtainable from the peripheral blood and the umbilical cord blood, [15] [16] [17] are a promising cell source for the fabrication of autologous antithrombogenic surfaces on tissue-engineered heart valve replacements. They have been used successfully for the repair of injured vessels and the neo-vascularization and regeneration of ischemic tissue, [18] [19] [20] [21] as well as for the coating of synthetic vascular grafts, 22 endothelialization of decellularized grafts in animal models, 23 and seeding of hybrid grafts. 24 In previous studies, we have demonstrated the feasibility of using human umbilical cord-derived cells for the engineering of cardiovascular constructs such as vascular grafts and patches, [25] [26] [27] resulting in layered immature proliferative tissues with beginning matrix formation. Here we focus on the in vitro engineering and maturation of living autologous biological active heart valve leaflets based on the umbilical cord as the only cell source as a further step toward the clinical realization of the pediatric tissue-engineering concept.
MATERIALS AND METHODS

Isolation and phenotyping of cells
Tissue and blood were harvested from fresh umbilical cords of healthy individuals after informed consent was obtained from the participants.
Human Wharton's jelly-derived myofibroblasts. Pieces (&8 mm 3 ) of umbilical cord tissue were obtained from Wharton's jelly using excision biopsy and placed in culture dishes as described before. 25 Outgrowing cells were expanded up to passage 11, and the cell phenotype was characterized using immunohistochemistry.
Human umbilical cord blood-derived EPCs. EPCs were isolated from the mononuclear fraction of 20 mL of fresh blood that was obtained by puncturing the human umbilical cord vein directly after delivery using density gradient centrifugation (Histopaque-1077, Sigma Chemical Company, St. Louis, MO). EPCs were cultured and differentiated in endothelial basal medium (EBMÔ-2; Cambrex, Walkersville, MD) containing growth factors and supplements (vascular endothelial growth factor (VEGF), human fibroblast growth factor (hFGF), human recombinant long-insulinlike growth factor-1 (R-3-IGF-1), human epidermal growth factor (hEGF), gentamycin and amphotericin (GA-1000), hydrocortisone, heparin, ascorbic acid, and 2% fetal bovine serum). Cultured cells were investigated for the expression of VEGF receptor 2 (VEGFR2; KDR, Flk-1/Fc Chimera, human recombinant, Sigma), lectin (Ulex europaeus agglutinin-1 (UEA-1), Sigma), and the uptake of acetylated low-density lipoprotein (ac-LDL; Dil-Ac-LDL, Biomedical Tech., Stoughton, MA). After 3 weeks, the endothelial phenotype was analyzed using immunohistochemistry.
Immunohistochemistry. Wharton's jelly-derived myofibroblasts (WMFs) and EPCs were cultured in chamber slides (Falcon; Becton Dickinson, Bedford, MA). After confluency, cells were washed with buffer and fixed with ethanol. Immunohistochemistry was performed using the Ventana Benchmark automated staining system (Ventana Medical Systems, Tucson, AZ) with Ventana reagents for the entire procedure. Primary antibodies against the following antigens were applied: vimentin (clone 3B4), desmin (clone D33), CD31 (clone JC/70A), Ki-67 (clone MIB-1), von Willebrand factor (vWF; affinity purified rabbit antibodies; all from DakoCytomation, Glostrup, Denmark); alpha-smooth muscle actin (a-SMA, clone 1A4; Sigma), and endothelial nitric oxide synthase type III (eNOS; affinity purified rabbit antibodies; BD Transduction Laboratories, San Diego, CA). Primary antibodies were detected using the Ventana iVIEW DAB detection kit, yielding a brown reaction product. For eNOS, the signal was enhanced using the amplification kit. Slides were counterstained with hematoxylin and glass cover-slipped.
Fabrication and seeding of scaffolds
Heart valve leaflet scaffolds were fabricated from a nonwoven polyglycolic-acid mesh (PGA, thickness: 1.0 mm, specific gravity: 69 mg/cm 3 , Albany Int., Albany, NY). PGA sheets were cut into 2.3 cm 2 leaflets (n ¼ 18), dip-coated with poly-4-hydroxybutyric acid (1% w/v P4HB, TEPHA Inc., Cambridge, MA), and three each attached to ringshaped supports (diameter: 20 mm). After drying, the scaffolds were sterilized with ethanol, and the leaflets were manually checked for mobility using repetitive up and down movement. WMFs (3.5Â106 cells/cm 2 ) were seeded individually onto each leaflet using fibrin as a cell carrier. 28 
Biochemical and mechanical conditioning protocol
After 15 min under humidified incubator conditions, one part of the heart valve leaflets (n ¼ 6) was cultured statically 3224 as a baseline, and the other part (n ¼ 12) was positioned into a custom-made diastolic pulse duplicator, described in detail previously. 29 Briefly, the diastolic pulse duplicator consisted of a bioreactor, in which the valve leaflets were placed, and a connected medium reservoir. The leaflets were perfused continuously (4 mL/min) with medium from the reservoir using a roller pump. Biological activity of leaflets was investigated by response to biochemical or mechanical stimulation or both. Two groups were formed with 6 leaflets each: Group 1 with the addition of the above-mentioned growth factors (VEGF, hFGF, R-3-IGF-1, and hEGF), as well as hydrocortisone and heparin, to the basal medium, Group 2 without. After 7 days, each group was divided into two subgroups. One group was continuously exposed to perfusion, and the other was exposed to perfusion and cyclic straining (mechanical stimulation). For cyclic straining, a dynamic pressure difference (12 mmHg; 1 Hz) over the leaflets was applied by releasing compressed air via a magnetic valve. After an additional 14 days, all valves were removed from the bioreactor and endothelialized with EPCderived cells (1.5Â106 cells/cm 2 ) on both leaflet sides. After seeding, leaflets were kept under humidified incubator conditions (378C, 5% carbon dioxide) for an additional 48 h and placed back into the bioreactor for 5 subsequent days with the same biochemical or mechanical stimulation as before. Static controls were treated in parallel.
Analysis of the engineered heart valve leaflets
After the in vitro culture time, representative samples of all leaflets were analyzed using the following techniques.
Histology and immunohistochemistry. After fixation in 4% phosphate-buffered formalin (pH 7.0) and paraffin embedding, 5-to 7-mm sections of each group were examined histologically using hematoxylin-eosin (H&E), TrichromMasson, and Movat pentachrome staining. Cell phenotypes of the neo-tissues were validated using immunohistochemistry performed as described above. For paraffin sections, antigen retrieval was done for all antibodies by heating with cell conditioner 1 (CC1, Ventana), except for CD31, for which predigestion with protease 1 (Ventana) for 4 min was required.
Quantitative evaluation of extracellular matrix elements. As an indicator for collagen, hydroxyproline content of dried samples was determined. 30 Sulphated glycosaminoglycans (GAGs) were detected colorimetrically using papain-digested samples and 1,9-di-methyl-methylene blue. 31 Native human heart valve tissues served as controls.
Determination of cell number. Cell numbers were determined from the papain digests after 50Âdilution in 10 mM Tris, 100 mM sodium chloride, 1 mM ethylenediaminetetraacetic acid (TNE) buffer (pH 7.4) and labeling of the deoxyribonucleic acid (DNA) using Hoechst dye (Bisbenzimide H33258, Fluka, Buchs, Switzerland). 32 After 10 min of incubation in a dark environment, the fluorescence was measured using fluorometry (Fluostar, BMG, Offenburg, Germany, 355 nm excitation/460 nm emission). The amount of DNA was calculated based on a standard curve using calf thymus DNA (Sigma).
Evaluation of mechanical properties. Mechanical properties of leaflet tissues (15Â5Â1 mm) were analyzed using a uniaxial tensile tester (Instron 4411, Canton, MA) equipped with a 10-N load cell. The crosshead speed was set to correspond to an initial strain rate of 1 min À1 . The recorded tensile force and displacement were transformed into stressstrain curves. Young's moduli were determined from the latter using linear fits to maximum slopes.
Scanning electron microscopy. Representative samples of leaflets of all groups were fixed in 2% glutaraldehyde for 24 h. After preparation, samples were sputtered with gold and investigated using a Zeiss Supra 50 VP Microscope (Zeiss, Jena, Germany).
Statistical analysis. The data were analyzed using SY-STAT version 10 (SPSS, Chicago, IL). Analysis of variance was performed to estimate the means and the significance of the categorical factors (biochemical and mechanical stimulation). Post hoc pairwise mean differences were estimated using the Bonferroni test, and the nonparametric Kruskal-Wallis test was performed. p < 0.05 was considered to be significant.
RESULTS
Morphology and phenotypes of cells
WMFs. Outgrowing WMFs expressed vimentin and a-SMA but lacked desmin. This staining pattern reflects a fibroblast-myofibroblast-like phenotype (VA type).
EPCs. After isolation, plated cells were initially round shaped. After 4 days, cells were attached and formed clusters. Two different types of EPCs were detected: spindlelike cells (80%) and polymorph cells (20%). Spindle-like cells died within 14 days, whereas polymorph EPCs (Fig.  1A) proliferated by forming colonies (Fig. 1B) . Outgrowing cells of these colonies stained positive for VEGFR-2 (data not shown) and demonstrated binding of UEA-1 (Fig. 1C) . Cells showed good proliferation under in vitro conditions and formed confluent cobblestone endothelial cell monolayers after 3 weeks (Fig.1D) with uptake of ac-LDL (Fig.  1E) and expression of CD31 (Fig. 1F), vWF (Fig. 1G) , and eNOS (Fig. 1H) .
Analysis of the engineered heart valve leaflets: macroscopic appearance. A macroscopic picture of the leaflets in HEART VALVE LEAFLETS BASED ON UMBILICAL-CORD PROGENITORS the ring-shaped support after 28 days in the bioreactor is presented in Fig. 2 . The leaflets were intact and pliable. Cells densely covered all leaflets.
Histology and immunohistochemistry. Leaflets grown under static conditions demonstrated cellular ingrowth but little tissue formation with H&E staining (Fig. 3A) and no production of extracellular matrix (ECM) elements with Trichrom-Masson-staining (Fig. 3B) . In contrast, leaflets of all bioreactor groups showed cellular tissue formation with production of ECMs. The tissue formation and cell phenotypes were independent of mechanical stimulation (perfusion/cyclic straining) but were influenced by biochemical stimulation. In response to biochemical stimulation, H&E staining revealed tissue formation organized in a layered manner with dense outer layers and lesser cellularity in the inner part (Fig. 3C) .
Trichrom-Masson-staining highlighted collagen at the outer layers (Fig. 3E) , whereas in the center, loosely arranged ECM substance was detectable, characterized as GAG by the Movat staining (Fig. 3G) . In contrast, without biochemical stimulation, leaflets (Group 2) showed less tissue layering (Fig. 3D ) but more production of collagen in all parts of the tissue (Fig. 3F ) and less production of GAG (Fig. 3H) . With detailed examination of the outer tissue layers, biochemically stimulated leaflets of Group 1 demonstrated denser cell layering with the H&E staining (Fig.  4A) than those of the un-stimulated Group 2 (Fig. 4B ). An endothelial cell lining, highlighted brownish in the CD31 staining, was found on the surfaces of Group 1 (Fig. 4C) and Group 2 (Fig. 4D) leaflets. Expression of vWF and eNOS confirmed the presence of endothelial cells (data not shown). Beneath the endothelia, a-SMA-positive cells were detectable in the denser outer layer in Group 1 leaflets (Fig. 4E) , whereas only a few a-SMA-positive cells were present in the leaflets of Group 2 (Fig. 4F) . Vimentin could be demonstrated throughout all leaflets, whereas desmin was not expressed (data not shown). Ki-67 nuclear protein was FIG. 1. Pre-seeding characterization of endothelial progenitor cells (EPCs). 12 days after isolation, polymorph EPCs began to proliferate (A, magnification:Â100). Outgrowing cells formed colonies (B, magnification:Â100) with binding of lectin (Ulex europeus agglutinin-1) (C, magnification: Â100). After 3 weeks, EPCs formed a confluent monolayer (D, magnification: Â50) with uptake of acetylated lowdensity lipoprotein (E, magnification:Â50), expression of CD31 (F, magnification:Â200), von Willebrand factor (G, magnification:Â400) and endothelial nitric oxyde synthase type III (H, magnification: Â200). Color images available online at www.liebertpub.com/ten. 3226 detectable in the outer layers of the neo-tissue and in the inner parts of the leaflets of both groups (Fig. 4G, H) .
Quantification of ECM elements. When leaflets were cultured statically, little collagen could be detected (0.2% of native content). The amount of GAG was only 28% of native tissue values, and the cell number was 54%. In contrast, in all leaflets of the bioreactor groups, the amount of GAG was comparable with that of native tissue but was higher in response to biochemical stimulation. The amount of hydroxyproline reached about 16% of the native tissue content and was higher in cells cultured without growth factors. The cell number, expressed as DNA content, was similar for all culture conditions, reaching up to 65% of native tissue values. For both groups, mechanical conditioning had no significant effect on the production of ECM elements. Fig. 5A summarizes the content of the ECM of leaflets of all bioreactor groups relative to native heart valve tissues. Fig. 5B represents ECM elements per cell number and further stresses the response to biochemical conditioning of ECM production. Cells of Group 1 produced significantly more GAG ( p < 0.001), whereas those of Group 2 produced significantly more collagen ( p < 0.02), expressed as hydroxyproline.
Mechanical properties. Table 1 summarizes the mechanical properties of the tissue-engineered leaflets maturated in the bioreactor. Leaflets of Group 2 were stiffer than those of Group 1, as indicated by the higher Young's Modulus. Mechanical stimulation influenced the mechanical properties of the tissue-engineered valves independent of the medium, as indicated by a trend of higher Young's moduli that could be observed in response to cyclic strain.
Scanning electron microscopy. All tissue-engineered leaflets showed confluent endothelial surfaces. Mechanical HEART VALVE LEAFLETS BASED ON UMBILICAL-CORD PROGENITORS but not biochemical stimulation affected the configuration and orientation of EPCs. Mechanically stimulated leaflets (Fig. 6A ) had a higher cell density than perfused ones (Fig.  6B) but showed less parallel cell alignment.
DISCUSSION
Pediatric cardiovascular tissue engineering aims at the fabrication of living, autologous, growing replacements for the repair of congenital malformations in newborns. For this concept, cells are ideally obtained during pregnancy to have the tissue-engineered replacement available at or shortly after birth, particularly to prevent secondary damage of the newborn's heart. A still unsolved problem for the fabrication of those replacements is the lack of appropriate prenatal cell sources. 7, 8, 33 In this study, umbilical cord-derived cells showed characteristics of a promising sole cell source for pediatric heart valve tissue engineering. WMFs exhibited phenotypic profiles of a fibroblast-myofibroblast lineage indicating substantial similarity to valvular interstitial cells. 34 Moreover, WMFs produced excellent ECM in amounts comparable with that of native tissue and other cells successfully used for in vitro and in vivo heart valve tissue-engineering studies. 7, 8 Isolated umbilical cord blood-derived EPCs differentiated into mature functional endothelial cells during cell expansion, as described before 35 and formed functional endothelial layers on the surfaces of tissue-engineered leaflets even under cyclic strain. This observation provides indications that the human umbilical cord blood-derived differentiated EPCs may also function as a non-thrombogenic cell layer in an in vivo environment with changing mechanical stresses. Experiments with prosthetic vascular graft surfaces seeded with blood-or bone marrow-derived EPCs have FIG. 4 . Immunohistochemical characteristics of the tissues in response to biochemical stimulation. Detailed examination of the outer tissue layer using hematoxylin-eosin staining showed denser cell layering for leaflets exposed to biochemical stimuli (A) than for unstimulated leaflets (B). Expression of CD31, highlighted brownish, confirmed the endothelial phenotype of cells in the topmost layer of stimulated (C) and un-stimulated (D) leaflets. A subendothelial cell layer expressing alpha-smooth muscle actin was formed under stimulation (E) but was not present without stimulation (F). Expression of Ki-67 nuclear protein demonstrated living, proliferating cells in all parts of the stimulated (G) and un-stimulated tissues (H). Color images available online at www.liebertpub.com/ten.
FIG. 5. Extracellular matrix analysis (A)
shows the amount of hydroxyproline (HYP, white), glycosaminoglycans (GAGs) (black), and cell number (deoxyribonucleic acid (DNA), patterned) of tissue-engineered leaflets, which were biochemically stimulated or not and strained or perfused, relative to native heart valve tissue and (B) contents of HYP and GAG per cell number. Means are given in mg matrix/mg DNA, error bars represent standard deviations, and asterisks represent significant differences.
3228
SCHMIDT ET AL.
shown evidence supporting these assumptions. 17, 23 Future in vivo experiments will elucidate this aspect.
When tissue-engineered constructs were allowed to respond to biochemical stimuli, a mature, layered tissue organization was found, comparable with that of native heart valves and tissue-engineered heart valves remodeled several weeks in vivo. 36 These are characterized by an outer layer (zona fibrosa) composed of collagen, a central layer (zona spongiosa) containing GAG, and a layer characterized by the presence of elastin fibers (zona ventricularis). 3 As in other studies, 7, 36 elastin could not be detected in the Movat staining used in this study but might be present on messenger ribonucleic acid level, which will be investigated in future studies. Furthermore, it is expected that elastin would be formed after implantation during the in vivo tissue remodeling process, as shown in previous studies. 36 The cell phenotypes in the engineered leaflets resembled those of native tissue, demonstrating a-SMA expression in the subendothelial layer of the zona fibrosa 37 and vimentin in all layers. 36 The changes in tissue formation, degree of maturation, and cell phenotypes in response to biochemical stimulation in this study confirm the biological activity, vitality, and remodeling capacity of cells, indicating a living adaptive tissue. In addition to the biological functionality and activity, the results demonstrate the importance of biochemical stimulation for the maturation of human tissues. This positive response, resulting in a more-layered and consequently more-mature tissue formation, may be related to and enhanced by the presence of mesenchymal progenitor cells in the Wharton's jelly of human umbilical cords, with multi-lineage potential, 9,10 because growth factors and cytokines such as VEGF, FGF, IGF-1, and EGF are known to influence tissue formation and differentiation. For instance, FGF orchestrates development by instructing different, uncommitted cell types to proliferate, differentiate, and organize into specific tissue lineages. 38 Furthermore, FGF and IGF-1 are known to stimulate collagen and GAG biosynthesis and play an important role in remodeling tissues derived from umbilical cord cells. [39] [40] [41] [42] [43] In the current study, the collagen content in the biochemically stimulated leaflet   FIG. 6 . Surface morphology. In scanning electron micrographs, mechanically stimulated heart valve leaflets (A) showed a higher cell density but less parallel alignment than perfused ones (B). were lower than in the un-stimulated leaflets. To elucidate the molecular mechanism behind this observation, further experiments are required. The formation of a subendothelial a-SMA-positive layer in this study may be related to the presence of the growth factors or of heparin (both used as medium supplements), because the latter and its nonanticoagulant derivatives are known to influence the expression of a-SMA in fibroblastic cells. 44 When tissue-engineered leaflets were exposed to mechanical stimulation, no significant effect on ECM protein production or cell phenotype could be detected. Previous studies reported that human vascular-derived cells produced more collagen and GAG under cyclic strain. 45 Different cell properties and differences in the straining protocol may explain this discrepancy. Nevertheless, we observed an influence of mechanical stimulation on the mechanical properties of the tissue-engineered leaflets. Strained leaflets revealed a tendency to higher stiffness, as found previously. 45 The differences in mechanical properties could be related to mechanical stimulation, 7, 46, 47 generating a different tissue organization by increased crosslinks between the ECM elements.
All stress-strain profiles showed a non-linear mechanical behavior similar to that of native leaflet tissues. In contrast, the initial scaffold material itself exhibited linear behavior, indicating that the measured mechanical properties can be mainly attributed to the newly formed tissues. However, it is difficult to estimate the exact contribution of the scaffold to the mechanical properties, because the polymer was not fully degraded after 4 weeks of in vitro culturing. The mechanical strength did not reach physiological values 48 during the investigated in vitro cultivation time period, suggesting further improvement of the mechanical loading protocol. This will be investigated in future studies, and the functionality of the engineered tissues in vivo will have to be demonstrated. For future clinical realization of the pediatric tissue-engineering concept, harvesting cells prenatally would be possible because umbilical cord blood is already routinely obtained using cordocentesis for genetic analysis. Tissue sampling from Wharton's jelly has not been established as a routine procedure but should be possible, because fetoscopic technology for tissue harvest is highly developed. [11] [12] [13] [14] It could be performed in an extended maneuver of the well-established umbilical cord puncturing for blood harvest and has to be evaluated in animal studies.
In summary, the successful in vitro engineering and maturation of biologically active heart valve leaflets using umbilical cords as the only prenatal cell source has been demonstrated. The main findings of this work are that (1) the fabrication of autologous heart valve leaflets with WMFs and umbilical cord blood-derived EPCs is feasible and that (2) the resulting tissues showed layered tissue organization similar to that of native heart valve leaflets and (3) demonstrated biological activity. The progenitor potential of the cells used in this study may increase the capacity for remodeling, repair, and regeneration and may open up novel strategies for heart valve tissue engineering based on the umbilical cord as the only prenatal cell source.
